<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Dreier McCracken | Activity</title>
	<link>https://www.catswannabecats.com/members/ouncerabbit78/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/ouncerabbit78/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Dreier McCracken.</description>
	<lastBuildDate>Wed, 10 Jun 2026 07:23:50 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ec8eb1c5947c0d7691eb7d83b5a8ca18</guid>
				<title>Dreier McCracken posted an update: Nevertheless, our investigation revealed that variations in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26812/</link>
				<pubDate>Wed, 11 Jun 2025 09:17:44 -0400</pubDate>

									<content:encoded><![CDATA[<p>Nevertheless, our investigation revealed that variations in the BCL2L1 copy number (CNVs) do not accurately forecast BCL-XL expression levels, although the BCL-XL protein concentration serves as a valuable indicator for anticipating GC cell susceptibility to BCL-XL-targeted compounds. Through our study, BCL-XL emerged as a promising drug target&hellip;<span class="activity-read-more" id="activity-read-more-26812"><a href="https://www.catswannabecats.com/activity/p/26812/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">521e3b0563811f65e609f588dbfe00cc</guid>
				<title>Dreier McCracken posted an update: A study into the clinical presentation of SF3B1-mutated [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23829/</link>
				<pubDate>Sun, 08 Jun 2025 10:41:24 -0400</pubDate>

									<content:encoded><![CDATA[<p>A study into the clinical presentation of SF3B1-mutated myelodysplastic syndrome with excess blasts (MDS-EB) was undertaken, with a focus on establishing the relationship between the presence of an SF3B1 mutation and therapeutic success and prognostic factors for patients with MDS-EB. This investigation utilized a retrospective case series study&hellip;<span class="activity-read-more" id="activity-read-more-23829"><a href="https://www.catswannabecats.com/activity/p/23829/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d5c6807d2912fd0a006930e46e53cb4</guid>
				<title>Dreier McCracken posted an update: In order to investigate five body size traits, a genome-wide [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/13929/</link>
				<pubDate>Mon, 02 Jun 2025 00:38:00 -0400</pubDate>

									<content:encoded><![CDATA[<p>In order to investigate five body size traits, a genome-wide association study (GWAS) was performed on 31 yak breeds and genetic resources. The compressed mixed linear model (CMLM) employed habitat-based individual clustering to ascertain kinship groupings. We have coined the term pCMLM method for this approach. Following pCMLM analysis of&hellip;<span class="activity-read-more" id="activity-read-more-13929"><a href="https://www.catswannabecats.com/activity/p/13929/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e8900e246d70183dac100c4f2c5bd862</guid>
				<title>Dreier McCracken became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/13845/</link>
				<pubDate>Sun, 01 Jun 2025 22:39:40 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>